Autoimmune gastritis: mode of presentation, associated findings, and results of endoscopy
. | Macrocytic, n = 29 . | Normocytic, n = 48 . | Microcytic, n = 83 . |
---|---|---|---|
Age, y, ± SD (M/F) | 62 ± 15 (17/12) | 58 ± 17 (18/30) | 41 ± 15 (18/65) |
Anemic, no. (%) | 18 (62) | 19 (40) | 83 (100) |
Low B12 level, no. (%) | 29 (100) | 44 (92) | 38 (46) |
Iron deficiency, no. (%) | 3 (10) | 24 (50) | 83 (100) |
Thyroid disease, no. (%) | 3 (10) | 14 (29) | 15 (18) |
Hypothyroid, no. | 3 | 12 | 12 |
Graves disease, no. | 0 | 1 | 2 |
Hashimoto thyroiditis, no. | 0 | 1 | 1 |
Vitiligo, no. (%) | 2 (7) | 0 (0) | 0 (0) |
Diabetes mellitus, no. (%) | 1 (3) | 4 (8) | 7 (8) |
Neurologic complications, no. (%) | 5 (17) | 2 (4) | 0 (0) |
Gastric histology, total no. | 13 | 24 | 32 |
Atrophic gastritis, no. (%) | 9 (69) | 13 (54) | 13 (41) |
Chronic gastritis, no. (%) | 2 (15) | 9 (38) | 18 (56) |
MALT lymphoma, no. (%) | 1 (8) | 1 (4) | 0 (0) |
Neoplasia, no., type (%) | 1, adenocarcinoma (8) | 1, polyp (4) | 1, polyp (3) |
. | Macrocytic, n = 29 . | Normocytic, n = 48 . | Microcytic, n = 83 . |
---|---|---|---|
Age, y, ± SD (M/F) | 62 ± 15 (17/12) | 58 ± 17 (18/30) | 41 ± 15 (18/65) |
Anemic, no. (%) | 18 (62) | 19 (40) | 83 (100) |
Low B12 level, no. (%) | 29 (100) | 44 (92) | 38 (46) |
Iron deficiency, no. (%) | 3 (10) | 24 (50) | 83 (100) |
Thyroid disease, no. (%) | 3 (10) | 14 (29) | 15 (18) |
Hypothyroid, no. | 3 | 12 | 12 |
Graves disease, no. | 0 | 1 | 2 |
Hashimoto thyroiditis, no. | 0 | 1 | 1 |
Vitiligo, no. (%) | 2 (7) | 0 (0) | 0 (0) |
Diabetes mellitus, no. (%) | 1 (3) | 4 (8) | 7 (8) |
Neurologic complications, no. (%) | 5 (17) | 2 (4) | 0 (0) |
Gastric histology, total no. | 13 | 24 | 32 |
Atrophic gastritis, no. (%) | 9 (69) | 13 (54) | 13 (41) |
Chronic gastritis, no. (%) | 2 (15) | 9 (38) | 18 (56) |
MALT lymphoma, no. (%) | 1 (8) | 1 (4) | 0 (0) |
Neoplasia, no., type (%) | 1, adenocarcinoma (8) | 1, polyp (4) | 1, polyp (3) |